- Home
- AQST vs MLP Comparison
AQST vs MLP Comparison
Compare AQST & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- MLP
- Stock Information
- Founded
- AQST 2004
- MLP 1909
- Country
- AQST United States
- MLP United States
- Employees
- AQST N/A
- MLP N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- MLP Real Estate
- Sector
- AQST Health Care
- MLP Finance
- Exchange
- AQST Nasdaq
- MLP Nasdaq
- Market Cap
- AQST 390.4M
- MLP 343.9M
- IPO Year
- AQST 2018
- MLP 1972
- Fundamental
- Price
- AQST $5.84
- MLP $17.76
- Analyst Decision
- AQST Strong Buy
- MLP
- Analyst Count
- AQST 7
- MLP 0
- Target Price
- AQST $10.29
- MLP N/A
- AVG Volume (30 Days)
- AQST 3.6M
- MLP 18.0K
- Earning Date
- AQST 11-03-2025
- MLP 11-13-2025
- Dividend Yield
- AQST N/A
- MLP N/A
- EPS Growth
- AQST N/A
- MLP N/A
- EPS
- AQST N/A
- MLP N/A
- Revenue
- AQST $44,132,000.00
- MLP $16,843,000.00
- Revenue This Year
- AQST N/A
- MLP N/A
- Revenue Next Year
- AQST $51.50
- MLP N/A
- P/E Ratio
- AQST N/A
- MLP N/A
- Revenue Growth
- AQST N/A
- MLP 74.59
- 52 Week Low
- AQST $2.12
- MLP $14.05
- 52 Week High
- AQST $6.43
- MLP $25.78
- Technical
- Relative Strength Index (RSI)
- AQST 62.29
- MLP 45.02
- Support Level
- AQST $5.47
- MLP $17.62
- Resistance Level
- AQST $5.93
- MLP $18.26
- Average True Range (ATR)
- AQST 0.36
- MLP 0.76
- MACD
- AQST 0.01
- MLP -0.22
- Stochastic Oscillator
- AQST 62.43
- MLP 7.35
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.